ArticleScientific reports2019

Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells.

Daniele Cretella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.